MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with N

Naftidrofuryl

Naftidrofuryl 100mg capsules

Use with caution

Stability notes for Naftidrofuryl 100mg capsules

Protect from light. Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the product naftidrofuryl 100mg capsules (Accord-UK Ltd).

Suppliers (7) of Naftidrofuryl 100mg capsules
Naftidrofuryl 100mg capsules (A A H Pharmaceuticals Ltd)
Naftidrofuryl 100mg capsules (Accord-UK Ltd)
Naftidrofuryl 100mg capsules (Alliance Healthcare (Distribution) Ltd)
Naftidrofuryl 100mg capsules (Medihealth (Northern) Ltd)
Naftidrofuryl 100mg capsules (Phoenix Healthcare Distribution Ltd)
Naftidrofuryl 100mg capsules (Sigma Pharmaceuticals Plc)
Praxilene 100mg capsules (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.